Ref (type)	Population	Outcome, Interventions	Results and statistical analysis	Effect size	Favours
Treatment failure
RCT Crossover design	187 people with suspected PCP; 163 people with confirmed diagnoses (only those with confirmed diagnoses and who gave consent were evaluated further)	Treatment failure end of treatment 27/68 (40%) with intravenous pentamidine 39/92 (42%) with TMP–SMX	RR 0.94 95% CI 0.64 to 1.37		Not significant